Ann: Heron receives Assays from recent drilling of G2 Lens, page-17

I'm revisiting this stock after a two year absence.

HRR used to be capitalised at $30m, with the non Woodlawn assets basically in for nothing.

Two years on, Woodlawn, pre $140m new equity, is still valued at $30m. The non core assets in Ardea are now worth $70m.

Zinc is at a 10 year high and Woodlawn is a fully funded through to production in 18/19.

Sounds quite good to me. Happy to be shot down in flames before I have a punt.